July 2025—Qiagen plans to launch three sample preparation instruments this year and next to expand its portfolio for automated sample preparation.
QIAsymphony Connect, the next generation of the QIAsymphony, is progressing toward a phased launch to selected customers this year. The system, for in vitro diagnostic use, addresses pathogen nucleic acid extraction and other applications and can process up to 96 samples at a time. It features improved automation capabilities for sample tracking and new applications, higher yield for increase in assay sensitivity, and digital connectivity.
QIAsprint Connect, on track for a 2026 launch, marks the company’s entry into automated high-throughput sample processing. The first demonstrations have showcased the system’s potential to process up to 192 samples per run with less than 30 minutes of hands-on time. The system supports a range of sample types, such as microbial, stool, and human tissues. QIAmini, also on track for launch next year, is a low-complexity entry into automation.
Qiagen, 240-686-7700